An extremely rare case of small-cell lung cancer harboring variant 2 of the EML4-ALK fusion gene

被引：32

作者：

Toyokawa, Gouji ^{[1
]}

Takenoyama, Mitsuhiro ^{[1
]}

Taguchi, Kenichi ^{[2
]}

Toyozawa, Ryo ^{[1
]}

Inamasu, Eiko ^{[1
]}

Kojo, Miyako ^{[1
]}

Shiraishi, Yoshimasa ^{[1
]}

Morodomi, Yosuke ^{[1
]}

Takenaka, Tomoyoshi ^{[1
]}

Hirai, Fumihiko ^{[1
]}

Yamaguchi, Masafumi ^{[1
]}

Seto, Takashi ^{[1
]}

Shimokawa, Mototsugu ^{[3
]}

Ichinose, Yukito ^{[1
]}

机构：

[1] Kyushu Natl Canc Ctr, Dept Thorac Oncol, Minami Ku, Fukuoka 8111395, Japan

[2] Kyushu Natl Canc Ctr, Inst Clin Res, Canc Pathol Lab, Fukuoka 8111395, Japan

[3] Kyushu Natl Canc Ctr, Inst Clin Res, Fukuoka 8111395, Japan

来源：

LUNG CANCER | 2013年 / 81卷 / 03期

关键词：

Small-cell lung cancer; Oncogenic driver mutation; EML4-ALK; MUTATIONS;

D O I：

10.1016/j.lungcan.2013.05.022

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Anaplastic lymphoma kinase (ALK) fuses echinoderm microtubule-associated protein-like 4 (EML4) to acquire a transforming activity in lung adenocarcinomas. However, the presence of an EML4-ALK fusion gene in other lung cancer histologies is an extremely rare phenomenon. A 43-year-old female was referred to our department due to dyspnea on effort and left back pain. Computed tomography (CT) showed a large mass in the upper lobe of the left lung and a massive left pleural effusion, while a CT-guided needle biopsy confirmed a diagnosis of small-cell lung cancer (SCLC). Surprisingly, the tumor was genetically considered to harbor the EML4-ALK fusion gene (variant 2). Although the patient underwent two regimens of cytotoxic chemotherapy for SCLC, she died approximately seven months after the administration of first-line chemotherapy. Our analysis of 30 consecutive patients with SCLC for EML4-ALK revealed that two patients, including the current patient and a patient we previously reported, harbored the EML4-ALK fusion gene. (c) 2013 Elsevier Ireland Ltd. All rights reserved.

引用

页码：487 / 490

页数：4

共 17 条

[11] Randomised phase III trial of carboplatin plus etoposide vs split doses of cisplatin plus etoposide in elderly or poor-risk patients with extensive disease small-cell lung cancer: JCOG 9702 [J].

Okamoto, H. ;

Watanabe, K. ;

Kunikane, H. ;

Yokoyama, A. ;

Kudoh, S. ;

Asakawa, T. ;

Shibata, T. ;

Kunitoh, H. ;

Tamura, T. ;

Saijo, N. .

BRITISH JOURNAL OF CANCER, 2007, 97 (02) :162-169

[12] Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer [J].

Peifer, Martin ;

Fernandez-Cuesta, Lynnette ;

Sos, Martin L. ;

George, Julie ;

Seidel, Danila ;

Kasper, Lawryn H. ;

Plenker, Dennis ;

Leenders, Frauke ;

Sun, Ruping ;

Zander, Thomas ;

Menon, Roopika ;

Koker, Mirjam ;

Dahmen, Ilona ;

Mueller, Christian ;

Di Cerbo, Vincenzo ;

Schildhaus, Hans-Ulrich ;

Altmueller, Janine ;

Baessmann, Ingelore ;

Becker, Christian ;

de Wilde, Bram ;

Vandesompele, Jo ;

Boehm, Diana ;

Ansen, Sascha ;

Gabler, Franziska ;

Wilkening, Ines ;

Heynck, Stefanie ;

Heuckmann, Johannes M. ;

Lu, Xin ;

Carter, Scott L. ;

Cibulskis, Kristian ;

Banerji, Shantanu ;

Getz, Gad ;

Park, Kwon-Sik ;

Rauh, Daniel ;

Gruetter, Christian ;

Fischer, Matthias ;

Pasqualucci, Laura ;

Wright, Gavin ;

Wainer, Zoe ;

Russell, Prudence ;

Petersen, Iver ;

Chen, Yuan ;

Stoelben, Erich ;

Ludwig, Corinna ;

Schnabel, Philipp ;

Hoffmann, Hans ;

Muley, Thomas ;

Brockmann, Michael ;

Engel-Riedel, Walburga ;

Muscarella, Lucia A. .

NATURE GENETICS, 2012, 44 (10) :1104-+

[13] Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors [J].

Sequist, Lecia V. ;

Waltman, Belinda A. ;

Dias-Santagata, Dora ;

Digumarthy, Subba ;

Turke, Alexa B. ;

Fidias, Panos ;

Bergethon, Kristin ;

Shaw, Alice T. ;

Gettinger, Scott ;

Cosper, Arjola K. ;

Akhavanfard, Sara ;

Heist, Rebecca S. ;

Temel, Jennifer ;

Christensen, James G. ;

Wain, John C. ;

Lynch, Thomas J. ;

Vernovsky, Kathy ;

Mark, Eugene J. ;

Lanuti, Michael ;

Iafrate, A. John ;

Mino-Kenudson, Mari ;

Engelman, Jeffrey A. .

SCIENCE TRANSLATIONAL MEDICINE, 2011, 3 (75)

[14] Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer [J].

Soda, Manabu ;

Choi, Young Lim ;

Enomoto, Munehiro ;

Takada, Shuji ;

Yamashita, Yoshihiro ;

Ishikawa, Shunpei ;

Fujiwara, Shin-ichiro ;

Watanabe, Hideki ;

Kurashina, Kentaro ;

Hatanaka, Hisashi ;

Bando, Masashi ;

Ohno, Shoji ;

Ishikawa, Yuichi ;

Aburatani, Hiroyuki ;

Niki, Toshiro ;

Sohara, Yasunori ;

Sugiyama, Yukihiko ;

Mano, Hiroyuki .

NATURE, 2007, 448 (7153) :561-U3

[15] Clinical outcome for EML4-ALK-positive patients with advanced non-small-cell lung cancer treated with first-line platinum-based chemotherapy [J].

Takeda, M. ;

Okamoto, I. ;

Sakai, K. ;

Kawakami, H. ;

Nishio, K. ;

Nakagawa, K. .

ANNALS OF ONCOLOGY, 2012, 23 (11) :2931-2936

[16] Epidermal Growth Factor Receptor Mutations in Small Cell Lung Cancer [J].

Tatematsu, Akiko ;

Shimizu, Junichi ;

Murakami, Yoshiko ;

Horio, Yoshitsugu ;

Nakamura, Shigeo ;

Hida, Toyoaki ;

Mitsudomi, Tetsuya ;

Yatabe, Yasushi .

CLINICAL CANCER RESEARCH, 2008, 14 (19) :6092-6096

[17] First Case of Combined Small-Cell Lung Cancer with Adenocarcinoma Harboring EML4-ALK Fusion and an Exon 19 EGFR Mutation in Each Histological Component [J].

Toyokawa, Gouji ;

Taguchi, Kenichi ;

Ohba, Taro ;

Morodomi, Yosuke ;

Takenaka, Tomoyoshi ;

Hirai, Fumihiko ;

Yamaguchi, Masafumi ;

Seto, Takashi ;

Takenoyama, Mitsuhiro ;

Sugio, Kenji ;

Ichinose, Yukito .

JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (12) :E39-E41

← 1 2 →